Vector Science and Therapeutics Corp. Announces Collaboration with SAFE Investment in Gary Payton's Scoreboard

Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity TORONTO, Oct. 7, 2026 /PRNewswire/ -- Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a strategic...

By Peptide Briefing · October 7, 2026 · 1 min read